drugset / Trial / NCT07869706
Systemic Antifungal Plus Q-Switched Nd:YAG Laser for Onychomycosis
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomized controlled trial aims to compare the efficacy and safety of systemic terbinafine combined with Q-switched Nd:YAG laser versus systemic terbinafine alone in the treatment of onychomycosis.
Timeline
- Start
- 2026-10-10
- Primary completion
- 2027-10-10
- Completion
- 2028-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Terbinafine | Small molecule | 250 mg | Oral |